Conscious sedation or local anesthesia during endovascular treatment for acute ischemic stroke by Graaf, R.A. van de et al.
ARTICLE CLASS OF EVIDENCE
Conscious sedation or local anesthesia during
endovascular treatment for acute ischemic stroke
Rob A. van de Graaf, MD,* Noor Samuels, MD,* Maxim J.H.L. Mulder, MD, PhD, Ismail Eralp, MD, PhD,
Adriaan C.G.M. van Es, MD, PhD, Diederik W.J. Dippel, MD, PhD, Aad van der Lugt, MD, PhD,
andBart J. Emmer,MD, PhD, for theMulticenter RandomizedClinical Trial of Endovascular Treatment of Acute
Ischemic Stroke in the Netherlands (MR CLEAN) Registry Investigators
Neurology® 2018;91:e19-e25. doi:10.1212/WNL.0000000000005732
Correspondence
Dr. van de Graaf
r.a.vandegraaf@
erasmusmc.nl
Abstract
Objective
To investigate the eﬀect of conscious sedation (CS) on functional outcome and complication
rates after intra-arterial treatment (IAT) for acute ischemic stroke (AIS) compared to the use of
local anesthesia (LA) at the puncture site only.
Methods
Patients undergoing IAT for AIS with CS or LA in the Erasmus UniversityMedical Center from
March 2014 to June 2016 were included for analysis. The primary outcome was the score on the
ordinal modiﬁed Rankin Scale (mRS). We compared CS to LA by ordinal logistic regression
with covariate adjustment using propensity scoring.
Results
In 146 AIS patients treated with IAT, use of CS was associated with a shift towards worse mRS
scores (odds ratio [OR] 0.4 [95% conﬁdence interval (CI) 0.2–0.7]) compared to LA. Mor-
tality after 90 days was higher in the CS group compared to the LA group (OR 2.3 [95% CI
1.0–5.2]). No diﬀerences between groups were noted with regard to procedure duration (8
minutes, β = 6.3 [95% CI −7.4 to 20.0]) or occurrence of procedure-related complications (OR
1.3 [95% CI 0.6–2.7]).
Conclusion
CS was associated with poor functional outcome and increased mortality rates compared to LA.
Furthermore, CS did not reduce duration of intervention or interventional complications. CS
during IAT for AIS is of no beneﬁt if LA is considered safe.
Classification of evidence
This study provides Class II evidence, because of nonrandom allocation, that for patients with
AIS undergoing IAT, LA rather than CS improves functional outcome.
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Anesthetic support is commonly used during intra-arterial
treatment (IAT) procedures for large vessel occlusions in
acute ischemic stroke (AIS).1 The aim of anesthetic support
during IAT is to reduce patient motion, increase patient
comfort, facilitate fast treatment, and minimize the risk of
complications. There are diﬀerent options for anesthetic
management during IAT; general anesthesia (GA), conscious
sedation (CS), or local anesthesia (LA) at the puncture site
only. CS is often considered as the ideal compromise during
IAT by preserving patient cooperation, comfort, and pro-
cedural speed compared to LA, and reducing medication
levels compared to GA. Although CS has become common
practice during IAT, the eﬀect on outcome is unknown.2 Post
hoc analysis of the Multicenter Randomized Clinical Trialof
Endovascular Treatment for Acute Ischemic Stroke in the
Netherlands (MR CLEAN) data showed that GA had a neg-
ative inﬂuence on treatment eﬀect of the intra-arterial pro-
cedure in AIS patients in comparison to non-GA (composite
of LA and CS).3 This was also conﬁrmed in the Highly Ef-
fective Reperfusion evaluated in Multiple Endovascular
Stroke trials (HERMES) collaboration.4 On the other hand,
recently published trials showed no advantage of CS on
neurologic improvement after IAT compared to GA.5,6We do
not know of studies comparing GA or CS with LA at the groin
puncture site only. Until now, it is unknown whether the use
of CS during IAT has any positive inﬂuence on outcome,
complications, or procedure times in AIS patients with a large
intracranial vessel occlusion, when compared to LA. The aim
of this study was to assess the eﬀect of CS on functional
outcome and occurrence of complications compared to LA.
Methods
Classification of evidence
We sought to answer the following research question: Does
CS in patients with AIS caused by a large intracranial vessel
occlusion of the anterior circulation improve functional out-
come in comparison to LA? Class II level of evidence is
assigned to this question.
Data source and study population
Patients who were enrolled in the MR CLEAN Registry were
studied. TheMRCLEANRegistry is a prospectively collected
database containing all patients who underwent IAT for IAS
in the Netherlands. The Registry started after the ﬁnal MR
CLEAN trial. All patients undergoing IAT (deﬁned as at least
entry into the angiography suite and arterial puncture) for
acute ischemic stroke in the anterior and posterior circulation
have been registered in the MR CLEAN Registry. For the
current study, we restricted our analysis to patients treated in
the Erasmus MC in Rotterdam from the start of the MR
CLEAN Registry in March 2014 until June 2016. As our
center was the only participating center in which the use of CS
during IAT was standard care for a deﬁned time period, we
restricted our analysis to single center data to minimize se-
lection bias. We additionally applied the following inclusion
criteria: arterial puncture within 6.5 hours of symptom onset;
age 18 years and older; intracranial proximal arterial occlusion
in the anterior circulation (intracranial carotid artery or middle
or anterior cerebral artery), demonstrated by CT angiography,
magnetic resonance angiography, or digital subtraction angi-
ography (DSA). We excluded patients with prestroke modiﬁed
Rankin Scale (mRS) score higher than 2 points, when GA was
performed as ﬁrst line of defense, or when type of anesthesia
was not documented. Study results are reported in accordance
with the Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) statement.7
Anesthetic procedure
The protocol in our institution stated that, if anesthetic sup-
port was available, CS should be started at the beginning of
the IAT procedure. When CS could not be initiated due to
unavailability of the attending anesthesiologist, the in-
tervention team would go ahead and an attempt would be
made to perform IAT directly under LA. If during the pro-
cedure it became apparent that IAT was not possible due to
restlessness of the patient, the anesthesiology department
would be requested to perform CS. The choice of anesthetic
agents used for CS was left to the discretion of the anesthe-
siologist. Medication strategy was based on either propofol or
remifentanil. Administered propofol doses ranged from 2 to 6
mg/kg/h and remifentanil doses from 1 to 4 μg/kg/h.
Study outcomes
The primary outcome was the mRS score (a 7-point scale
ranging from 0 “no symptoms” to 6 “dead”) at 90 days after
IAT. Secondary outcomes included a score of 2 or less on the
mRS, indicating good functional outcome; death within 7, 30,
and 90 days postintervention; and NIH Stroke Scale (NIHSS)
score indicating neurologic deﬁcit on a 0–42 scale at 24–48
hours postintervention.8,9 A higher NIHSS score indicates
a more severe deﬁcit. Procedure-related outcome measures
includedmodiﬁed thrombolysis in cerebral infarction (mTICI)
score on DSA, total procedure time, and procedure-related
complications. The mTICI score ranges from 0 (no antegrade
Glossary
acOR = adjusted common odds ratio; AIS = acute ischemic stroke; CI = conﬁdence interval; CS = conscious sedation; DSA =
digital subtraction angiography; ED = emergency department; eTICI = modiﬁed thrombolysis in cerebral infarction including
a 2C grade; GA = general anesthesia; IAT = intra-arterial treatment; LA = local anesthesia; MR CLEAN = Multicenter
Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands; mRS = modiﬁed Rankin
Scale; mTICI = modiﬁed thrombolysis in cerebral infarction; NIHSS = NIH Stroke Scale.
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reperfusion of the occluded vascular territory) to 3 (complete
antegrade reperfusion of the occluded vascular territory). For
eTICI, grade 2C (slow ﬂow in a few distal cortical vessels or
presence of small distal cortical emboli, corresponding to
90%–99% reperfusion) was added to the original mTICI
score.10 Procedure-related complications included vessel per-
foration, vessel dissection, new clot, distal thrombus, vasospasm,
hemorrhage, and other. Procedure-related complications and
eTICI score were assessed by core laboratory. Serious adverse
events included symptomatic intracranial hemorrhage, pro-
gression of ischemic stroke, new ischemic stroke, pneumonia,
other infections, cardiac ischemia, extracranial hemorrhage, al-
lergic reactions, and other adverse events. Investigators who
assessed primary and secondary outcomes, procedure-related
outcome, and procedure-related complications were not aware
of the type of anesthetic support during the procedure.
Statistical methodology and procedures
Based on the intention-to-treat principle, patients converted
from LA to CS during the IAT procedure were included in the
LA group. In case the anesthesia team was not available just
before starting the IAT procedure and the IAT procedure
seemed unsafe under LA (due to excessive movement), the
anesthesia team was called immediately without starting the
procedure to increase procedural safety. If the decision for
anesthesia in the form of CS was made before groin puncture,
the patient was included in the CS group. For variables with
missing values in fewer than 5% of patients, we used single
imputation by mean for continuous variables and by mode for
categorical variables. Normality assessment of data was per-
formed both visually and by means of the Kolmogorov-
Smirnov test. One-way analysis of variance was used for
parametric and Kruskal-Wallis test for nonparametric testing.
Both categorical and dichotomous variables were tested using
crosstabs and are shown as percentages.
Possible selection bias was addressed by performing adjustment
for covariates by propensity score for both primary and sec-
ondary outcomes. Variables related to anesthetic management
and outcome were selected based on clinical experience and
previous literature. The saturated propensity model included
the variables age, sex, previous stroke, diabetes mellitus, atrial
ﬁbrillation, hypertension, history of myocardial infarction, pe-
ripheral artery disease, prestroke mRS score, NIHSS at baseline,
aphasia score, preinterventional eTICI score, and time from
stroke onset to groin puncture. For each case, a propensity score
was calculated using the propensity model. This propensity
score, yielding the probability for a patient to receive anesthetic
management in the form of CS given the baseline character-
istics, was then incorporated in a regression model. Propensity
score adjustment was performed by means of a logistic re-
gression model for binary outcomes. The propensity score was
then used in an ordinal logistic regression model to adjust the
estimate of the eﬀect of CS on the mRS score. This eﬀect is
expressed as an adjusted common odds ratio (acOR) with 95%
conﬁdence interval (CI), as the mRS is an ordered categorical
outcome. A p value of < 0.05 was considered signiﬁcant in all
applied tests. All statistical analyses were performed with Stata
14.0 software (StataCorp, College Station, TX).
Standard protocol approvals, registrations,
and patient consents
The MR CLEAN Registry was reviewed and approved by the
medical ethics committee and research board of the Erasmus
MC, University Medical Center, Rotterdam, the Netherlands
(MEC-2014-235). This approval extends to all participating
centers in the Netherlands. Study candidates received verbal
and written explanation of the study and had the opportunity
to opt out. Coded data were obtained and stored at Erasmus
MC, and scientiﬁc analyses were approved and supervised by
a central writing committee. The MR CLEAN Registry study
protocol is available onmrclean-trial.org/docs/latestprotocol.pdf.
Data availability
Data cannot be made available, as no patient approval has
been obtained for sharing coded data. However, syntax ﬁles
and output of statistical analyses (Stata 14.0) will be made
available upon request.
Results
Patient characteristics
Between March 2014 and June 2016, 205 patients underwent
IAT at the Erasmus MC. A total of 146 patients met the
inclusion criteria (ﬁgure). Sixty patients (41%) received CS
and 86 patients (59%) LA at the groin puncture site only
during IAT. Patients treated with IAT under CS less often had
a history of previous stroke than patients treated without CS
(1.7% vs 14.0%; p = 0.01) (table 1).
Figure Flowchart of patients included from Erasmus Med-
ical Center (Erasmus MC) in the Multicenter Ran-
domized Clinical Trial of Endovascular Treatment
for Acute Ischemic Stroke (MR CLEAN) registry from
March 2014 to June 2016
CS = conscious sedation; LA = local anesthesia;mRS =modified Rankin Scale.
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Table 1 Baseline characteristics
CS (n = 60) LA (n = 86) p Value
Patient characteristics
Age, y, mean (SD) 65.9 (14.2) 69.2 (13.5) 0.16
Male sex, n (%) 32 (53.3) 51 (59.3) 0.47
NIHSS, median (IQR) 15 (9.0–19) 14 (10–18) 0.46
Hemisphere, n (%)
Left 22 (44.9) 30 (39.5) 0.55
Right 27 (55.1) 46 (60.5) 0.55
Systolic BP, mean (SD) 152.7 (27.0) 151.3 (24.0) 0.74
Diastolic BP, mean (SD) 81.7 (16.7) 82.7 (15.6) 0.72
IVT, n (%) 48 (80.0) 65 (75.6) 0.53
Medical history, n (%)
Previous stroke 1 (1.7) 12 (14.0) 0.01
Atrial fibrillation 9 (15.0) 16 (18.6) 0.57
Hypertension 28 (47.5) 48 (55.8) 0.32
Diabetes mellitus 10 (16.7) 14 (16.3) 0.95
Myocardial infarction 6 (10.0) 11 (12.8) 0.61
Peripheral arterial disease 1 (1.7) 8 (9.3) 0.06
Prestroke mRS 0.96
0 52 (92.9) 78 (92.9)
1 1 (1.8) 2 (2.4)
2 3 (5.4) 4 (4.8)
Imaging
Occluded segment, n (%)
M1 31 (64.6) 31 (54.4) 0.29
M2 12 (25.0) 19 (33.3) 0.35
ICA 2 (4.2) 3 (5.3) 0.79
ICA-T 3 (6.3) 4 (7.0) 0.88
Reperfusion before intervention (eTICI), n (%) 0.16
0 45 (79.0) 62 (80.5)
1 9 (15.8) 6 (7.8)
2A 0 (0) 4 (5.2)
2B 2 (3.5) 1 (1.3)
2C/3 1 (1.8) 4 (5.2)
ASPECTS, median (IQR) 8 (7–10) 9 (8–10) 0.05
Workflow
Time from stroke onset to IVT, min, median (IQR) 70 (55–111) 72 (55–87) 0.89
Time from stroke onset to admission ED,a min, median (IQR) 166 (126–210) 138 (101–189) 0.06
Time from admission EDa to groin puncture, min, median (IQR) 55 (35–79) 54 (37–72) 0.98
Continued
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Logistics
Time from stroke onset to admission to the emergency de-
partment (ED) of the Erasmus MC (intervention center) did
not diﬀer between the groups. Admission time was 166
minutes in the patients receiving CS vs 138 minutes for
patients receiving LA, but this was not diﬀerent (p = 0.06).
Time from admission to the ED of the intervention center to
groin puncture did not diﬀer between groups (55 vs 54
minutes, p = 0.98).
Outcome
Patients who underwent CS were more likely to have poor
mRS scores at 90 days compared to LA (acOR 0.4 [95% CI
0.2–0.7]). Good functional outcome (mRS score ≤2) at 90
days was less often seen in patients who underwent CS
compared to LA (OR 0.4 [95% CI 0.2–0.8]). Mortality within
30 days post IAT was higher in the CS group compared to the
LA group (17/60 vs 10/86, OR 2.6 [95% CI 1.0–6.4]). Also,
mortality within 90 days post IAT was higher in the CS group,
35% (21/60) vs 16% (14/86) in the LA group (OR 2.3 [95%
CI 1.0–5.2]).
NIHSS at 24–48 hours post IAT was 12 in the patients re-
ceiving CS and 6 in the patients receiving LA, but not diﬀerent
(β 5.75 [interquartile range −0.9 to 12.6]). Successful re-
canalization (eTICI ≥ 2B) was achieved in 72% (105/146) of
all patients, without diﬀerence between the CS and LA group
(OR 0.5 [95% CI 0.2–1.0]). Successful recanalization at the
eTICI ≥ 2C level on DSA was less often seen in the CS group
(OR 0.4 [95% CI 0.2–0.8]). There was no diﬀerence in time
of stroke onset to reperfusion between the CS group and the
LA group (284 vs 256 minutes, β 10.7 [95% CI −14.0 to
35.3]). Also, total procedure time, procedure-related com-
plications, and serious adverse events did not diﬀer between
groups (table 2). Conversion of anesthetic management was
reported in 4 patients: twice from LA to CS, once from LA to
GA, and once from CS to GA.
Discussion
In this cohort study, CS during IAT was associated with poor
functional outcome and higher mortality compared to LA.
Reperfusion rates, procedure duration, procedure-related
complications, and serious adverse events did not diﬀer
between the 2 groups. Therefore, our results suggest that
functional outcome is less inﬂuenced by LA than by CS as an
anesthetic approach during IAT, bearing in mind that due to
patient movement and need for procedural comfort the use of
CS is sometimes inevitable.
Studies on anesthetic approaches during IAT focused only on
GA compared to other types of anesthetic support (i.e., CS or
non-GA) with contrasting results.4–6,11 Some suggested
mechanisms present in both GA and CS may lead to worse
outcome in comparison to LA.12,13 Delay in treatment initi-
ation is considered an important disadvantage of GA, with
eﬀect on functional outcome.14 As “time is brain,” 1 single
hour of delay leads to a 6% decrease in good functional out-
come.15 However, time from admission to the ED of the
intervention center to groin puncture did not diﬀer between
patients who underwent IAT with CS compared to LA. In
addition, patients undergoing CS have an increased risk of
pulmonary aspiration, as they usually have not fasted before
an IAT procedure.16 Other mechanisms potentially contrib-
uting to poor functional outcome after IAT may include the
detrimental eﬀect of periprocedural hypotension or the pos-
sible eﬀects of anesthetic agents on the brain itself (i.e., direct
neurotoxic).13,17–19
Time from stroke onset to admission to the ED of the in-
tervention center was 28 minutes longer in the CS group,
although not diﬀerent from the LA group. This delay con-
tributed to the longer time from stroke onset to reperfusion
seen in the CS group. Notably, the net eﬀect of CS on out-
come remained, even with incorporating time from stroke
onset to groin puncture in the propensity score. Time from
admission to the ED of the intervention center to groin
puncture was similar between patients who underwent IAT
with CS or LA. Consequently, we were not able to detect
a delay in the CS group regarding initiation of anesthetic
management. Successful recanalization on eTICI ≥2C level
was less often seen in the CS group. CS did not result in lower
complication rates, contrary to the common belief that CS
increases the safety of the procedure. Nonetheless, because of
our relatively small sample size, these ﬁndings need to be
conﬁrmed in a larger prospective randomized study. Con-
cerning our intention-to-treat principle for minimization of
selection bias, the occurrence of conversion could not have
inﬂuenced the results in favor of the LA group.
Table 1 Baseline characteristics (continued)
CS (n = 60) LA (n = 86) p Value
Time from stroke onset to groin puncture, min, median (IQR) 224.5 (166–282.5) 195 (167–245) 0.08
Abbreviations: ASPECTS = Alberta Stroke Program Early Computed Tomography Score; BP = blood pressure; CS = conscious sedation; ED = emergency
department; eTICI = modified thrombolysis in cerebral infarction including a 2C grade; ICA = internal carotid artery; ICA-T = internal carotid artery terminus;
IQR = interquartile range; IVT = IV thrombolysis; LA = local anesthesia at the groin puncture site;M(segment) =middle cerebral artery; NIHSS =NIH Stroke Scale.
Continuous data are presented as mean (SD) for normal distributed data or as median (IQR) for skewed data.
a Intervention center, Erasmus MC, Rotterdam.
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This study has several limitations. In this single-center study,
patients were not randomized between CS and LA. Never-
theless, its observational design has the advantage that we
observe the procedures in everyday practice, and the pro-
pensity score adjustment was performed to adjust for po-
tential confounders between groups. Furthermore, results
could have been confounded by variables not accounted for in
the propensity model (“unmeasured confounding”).20 Con-
founding by indication might have been introduced, apart
from protocol-based anesthetic management (CS), as the
condition of the patient also inﬂuences the choice made by
the intervention team. We tried to prevent this by saturating
the propensity model. Regarding the baseline characteristics
included in the propensity model, previous stroke and time
from onset of stroke until groin puncture were distributed in
disadvantage of CS. Another limitation is the lack of data on
blood pressure during the IAT procedure. The generaliz-
ability of the results reported in this study is also limited by the
Table 2 Effect of conscious sedation (CS) in patients undergoing intra-arterial treatment for acute ischemic stroke after
propensity score adjustment
CS (n = 60) LA (n = 86)
Effect
measure
Adjusted valuea
(95% CI)
Primary outcome
mRS at 90 d, median (IQR) 4 (3–6) 3 (2–4) acOR 0.4 (0.2 to 0.7)
Secondary outcomes, clinical, n (%)
mRS ≤2 at 90 d 13 (22) 40 (47) OR 0.4 (0.2 to 0.8)
Mortality at 7 d 9 (15) 6 (7) OR 1.8 (0.6 to 5.6)
Mortality at 30 d 17 (28) 10 (12) OR 2.6 (1.0 to 6.4)
Mortality at 90 d 21 (35) 14 (16) OR 2.3 (1.0 to 5.2)
NIHSS 24–48 h, median (IQR) 12 (7–19) 6 (4–14) β 5.9 (−0.9 to 12.6)
Secondary outcome, radiologic
Reperfusion after intervention (eTICI ≥ 2B), n (%) 38 (63) 67 (78) OR 0.5 (0.2 to 1.0)
Reperfusion after intervention (eTICI ≥ 2C), n (%) 23 (38) 53 (62) OR 0.4 (0.2 to 0.8)
Secondary outcomes, time difference
Time from stroke onset to reperfusion, min, median (IQR) 284 (237–347) 256 (225–297) β 10.7 (−14.0 to 35.3)
Duration of procedure, min, mean (SD) 77 (40) 69 (38) β 6.3 (−7.4 to 20.0)
Secondary outcomes, safety measures, and serious adverse events
Procedure-related complications, n (%) 23 (38) 25 (29) OR 1.3 (0.6 to 2.7)
Serious adverse events, n (%)
Symptomatic ICH 3 (5) 3 (3) OR 1.7 (0.3 to 10.2)
ECH 2 (3) 1 (1) OR 2.4 (0.2 to 29.1)
Progression of stroke 9 (15) 8 (9) OR 1.3 (0.5 to 3.7)
New ischemic stroke 2 (3) 3 (3) OR 0.8 (0.1 to 5.6)
Cardiac ischemia 0 1 (1) OR —
Pneumonia 12 (20) 9 (10) OR 2.1 (0.8 to 5.8)
Allergic reaction 0 0 OR —
Other infections 2 (3) 0 OR —
Other 10 (17) 9 (10) OR 1.4 (0.5 to 3.7)
Abbreviations: acOR = adjusted common odds ratio; CI = confidence interval; ECH = extracranial hemorrhage; eTICI = modified thrombolysis in cerebral
infarction including a 2C grade; ICH = intracranial hemorrhage; LA = local anesthesia at the groin puncture site; mRS = modified Rankin Scale; NIHSS = NIH
Stroke Scale; OR = odds ratio.
Variables in the propensity score model: age, sex, previous stroke, diabetes mellitus, atrial fibrillation, hypertension, history of myocardial infarction,
peripheral artery disease, prestroke mRS score, NIHSS at baseline, aphasia score, preinterventional eTICI score, time from stroke onset to groin puncture.
a Values of CS vs local anesthesia, adjusted by propensity score.
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lack of research on this topic and heterogeneity of IAT
management between centers. Nevertheless, CS appears to
inﬂuence outcome after IAT, which could be of relevance to
physicians in the decision-making process for the most ap-
propriate anesthetic management during IAT. Based on our
results, a randomized trial evaluating outcome after IAT with
LA, CS, or GA seems justiﬁed.
We found that CS is associated with poor functional outcome
and higher mortality in patients who underwent IAT for AIS.
Furthermore, CS did not reduce duration of intervention or
procedure-related complications and did not increase reper-
fusion rates. Our results suggest that functional outcome is
less inﬂuenced by LA than by CS as an anesthetic approach
during IAT.
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